SERPINE1 and lung carcinoma: Similarly, another protease inhibitor, the plasminogen activator inhibitor 1 (PAI-1) has been shown to be associated with poor prognosis in breast cancer (Grondahl-Hansen et al, 1993), lung cancer (Pedersen et al, 1994) and CRC (Nielsen et al, 1998).